Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Tolerability of CHF 1535 vs Seretide in Moderate to Severe Asthma
NCT00394368Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Nov 2004; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00394368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394368.